These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 33543457)

  • 1. Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.
    Küçüktürkmen B; Rosenholm JM
    Adv Exp Med Biol; 2021; 1295():99-120. PubMed ID: 33543457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications.
    Wang X; Zheng M; Raza F; Liu Y; Wei Y; Qiu M; Su J
    Curr Pharm Des; 2022; 28(2):151-164. PubMed ID: 34766889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules.
    Sarkar S; Ekbal Kabir M; Kalita J; Manna P
    Chembiochem; 2023 Apr; 24(7):e202200672. PubMed ID: 36719179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications.
    Živojević K; Mladenović M; Djisalov M; Mundzic M; Ruiz-Hernandez E; Gadjanski I; Knežević NŽ
    J Control Release; 2021 Sep; 337():193-211. PubMed ID: 34293320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
    Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations.
    Djayanti K; Maharjan P; Cho KH; Jeong S; Kim MS; Shin MC; Min KA
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
    Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
    Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
    Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.
    Castillo RR; Lozano D; González B; Manzano M; Izquierdo-Barba I; Vallet-Regí M
    Expert Opin Drug Deliv; 2019 Apr; 16(4):415-439. PubMed ID: 30897978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology.
    Huang R; Shen YW; Guan YY; Jiang YX; Wu Y; Rahman K; Zhang LJ; Liu HJ; Luan X
    Acta Biomater; 2020 Oct; 116():1-15. PubMed ID: 32911102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery.
    Sábio RM; Meneguin AB; Ribeiro TC; Silva RR; Chorilli M
    Int J Pharm; 2019 Jun; 564():379-409. PubMed ID: 31028801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
    Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
    Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
    Dilnawaz F
    Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.